東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The role of deleterious passengers i...

McFarland, Christopher D.

FindBook

Google Book

Amazon

博客來

The role of deleterious passengers in cancer.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The role of deleterious passengers in cancer./
作者:	McFarland, Christopher D.
面頁冊數:	148 p.
附註:	Source: Dissertation Abstracts International, Volume: 76-03(E), Section: B.
Contained By:	Dissertation Abstracts International76-03B(E).
標題:	Biophysics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3645028
ISBN:	9781321335033

The role of deleterious passengers in cancer.
McFarland, Christopher D.

The role of deleterious passengers in cancer. - 148 p.

Source: Dissertation Abstracts International, Volume: 76-03(E), Section: B.

Thesis (Ph.D.)--Harvard University, 2014.

This item must not be sold to any third party vendors.

The development of cancer from a population of precancerous cells is a rapid evolutionary process. During progression, cells evolve several new traits for survive and proliferation via a few key 'driver' mutations. However, these few driver alterations reside in a cancer genome alongside tens of thousands of additional 'passenger' mutations. Passengers are widely believed to have no role in cancer, yet many passengers fall within functional genomic elements that may have potentially deleterious effects on the cancer cells. Here we investigate the potential of moderately deleterious passengers to accumulate and alter neoplastic progression.

ISBN: 9781321335033Subjects--Topical Terms:

518360
Biophysics.

The role of deleterious passengers in cancer.
LDR:03509nmm a2200349 4500 001 2060543
005 20150828095242.5
008 170521s2014 ||||||||||||||||| ||eng d
020 $a 9781321335033
035 $a (MiAaPQ)AAI3645028
035 $a AAI3645028
040 $a MiAaPQ $c MiAaPQ
100 1 $a McFarland, Christopher D. $3 3174712
245 1 4 $a The role of deleterious passengers in cancer.
300 $a 148 p.
500 $a Source: Dissertation Abstracts International, Volume: 76-03(E), Section: B.
500 $a Adviser: James M. Hogle.
502 $a Thesis (Ph.D.)--Harvard University, 2014.
506 $a This item must not be sold to any third party vendors.
520 $a The development of cancer from a population of precancerous cells is a rapid evolutionary process. During progression, cells evolve several new traits for survive and proliferation via a few key 'driver' mutations. However, these few driver alterations reside in a cancer genome alongside tens of thousands of additional 'passenger' mutations. Passengers are widely believed to have no role in cancer, yet many passengers fall within functional genomic elements that may have potentially deleterious effects on the cancer cells. Here we investigate the potential of moderately deleterious passengers to accumulate and alter neoplastic progression.
520 $a Evolutionary simulations suggest that moderately-deleterious passengers accumulate during progression and largely evade natural selection. Accumulation is possible because of cancer's unique evolutionary constraints: an initially small population size, an elevated mutation rate, and a need to acquire several driver mutations within a short evolutionary timeframe. Cancer dynamics can be theoretically understood as a tug-of-war between rare, strongly-beneficial drives and frequent mildly-deleterious passengers. In this formalism, passengers present a barrier to cancer progression describable by a critical population size, below which most lesions fail to progress, and a critical mutation rate, above which cancers collapse. In essence, cancer progression can be subverted by its own unique evolutionary constraints.
520 $a The collective burden of passengers explain several oncological phenomena that are difficult to explain otherwise. Genomics data confirms that many passengers are likely damaging and have largely evaded negative selection, while age-incidence curves and the distribution of mutation totals suggests that drivers and passengers exhibit competing effects. These data also provide estimates of the strength of drivers and passengers.
520 $a Finally, we use our model to explore cancer treatments. We identify two broad regimes of adaptive evolutionary dynamics and use these regimes to understand outcomes from various treatment strategies. Our theory explains previously paradoxical treatment outcomes and suggest that passengers could serve as a biomarker of response to mutagenic therapies. Deleterious passengers are targetable by either (i) increasing the mutation rate or (ii) exacerbating their deleterious effects. Our results suggest a unique framework for understanding cancer progression as a balance between driver and passenger mutations.
590 $a School code: 0084.
650 4 $a Biophysics. $3 518360
650 4 $a Evolution & development. $3 3172418
650 4 $a Genetics. $3 530508
650 4 $a Oncology. $3 751006
690 $a 0786
690 $a 0412
690 $a 0369
690 $a 0992
710 2 $a Harvard University. $b Biophysics. $3 3174713
773 0 $t Dissertation Abstracts International $g 76-03B(E).
790 $a 0084
791 $a Ph.D.
792 $a 2014
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3645028